Clinical Trial Update: Determination of the Minimal Concentration of Antifibrinolytics Required to Inhibit t-PA-activated Fibrinolysis

View source ↗

Summary

A completed study evaluating the minimum concentration of antifibrinolytics required to inhibit t-PA–activated fibrinolysis, using rotational thromboelastometry…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Snippet

Sponsor: Boston Children's Hospital | Conditions: Congenital Heart Disease, Fibrinolysis | Status: COMPLETED